Miostat (Carbachol)

Carbachol, the active ingredient in Miostat, is a muscarinic agonist presented as a sterile ophthalmic solution for intraocular use. It is employed to lower intra‑ocular pressure and to induce pupil constriction during eye procedures, benefiting patients with glaucoma or requiring surgical miosis.

GNH USA supplies Miostat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Carbachol acts as a miotic agent within the ocular pressure regulation pathway. It is indicated for: - Glaucoma (open‑angle and acute angle‑closure): reduces intra‑ocular pressure by enhancing aqueous humor outflow. - Induction of miosis during ophthalmic surgery: produces rapid pupil constriction to improve surgical access. - Ocular hypertension: lowers intra‑ocular pressure to prevent progression to glaucoma.

Carbachol may cause ocular and systemic reactions following intraocular administration.

Common Side Effects: - Transient blurred vision: temporary loss of visual clarity. - Eye pain or discomfort: mild irritation after instillation. - Conjunctival redness: mild hyperemia of the eye. - Increased lacrimation: excess tearing. - Headache: mild to moderate. - Brow ache: localized discomfort.

Serious or Rare Side Effects: - Severe ocular inflammation: uveitis or iritis requiring medical attention. - Allergic reaction: swelling, rash, or anaphylaxis. - Systemic cholinergic effects: bradycardia, hypotension, or bronchospasm. - Persistent miosis: prolonged pupil constriction affecting vision. - Corneal edema: swelling of the cornea. - Vision loss: rare but serious loss of visual acuity.

When using Carbachol, clinicians should observe several safety measures. - Assess intra‑ocular pressure before initiation: ensure baseline measurement. - Avoid in narrow‑angle glaucoma: risk of acute angle closure. - Caution in patients with asthma or COPD: potential bronchospasm. - Monitor for systemic cholinergic signs: bradycardia, hypotension. - Pregnancy and breastfeeding safety unknown: use only if benefit outweighs risk. - Store at room temperature: keep in original container, protect from light and moisture.

Carbachol can interact with other medications that affect muscarinic pathways.

Major Interactions (Avoid): - Antimuscarinic agents (e.g., atropine, scopolamine): antagonize Carbachol’s ocular effect. - Systemic cholinesterase inhibitors (e.g., pyridostigmine): may potentiate cholinergic activity and increase systemic side effects.

Moderate Interactions (Monitor Closely): - Other miotic agents (e.g., pilocarpine): additive pupil constriction. - Topical non‑steroidal anti‑inflammatory drugs: may increase ocular irritation. - Systemic antihistamines: could reduce efficacy of pupil constriction.